Hiroaki Tanaka, PhD MBA, is currently the Chief Executive Officer at EVBiome, where they lead strategic initiatives in biotechnology. With extensive experience in bioinformatics, they previously served as Director at Genset S.A. and held several leadership roles in personalized medicine at Merck Serono and Debiopharm International SA. Hiroaki has contributed to significant projects across the pharmaceutical industry, including strategic planning and the implementation of innovative marketing initiatives. They also participate on several boards, including AEVA biotech and Abionic, showcasing their commitment to advancing healthcare innovation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices